Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M483Revenue $M163Net Margin (%)-31.2Altman Z-Score0.6
Enterprise Value $M445EPS $-0.8Operating Margin %-25.1Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.7Pre-tax Margin (%)-31.0Higher ROA y-yN
Price/Book2.310-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %--Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow29.3y-y EBITDA Growth Rate %--ROA % (ttm)-11.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-22.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M68.2ROIC % (ttm)-21.4Gross Margin Increase y-yN

Gurus Latest Trades with SPPI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SPPIJoel Greenblatt 2012-12-31 Sold Out -0.02%$10.64 - $12.31
($11.39)
$ 7.09-38%Sold Out0
SPPIJoel Greenblatt 2012-09-30 Buy 0.02%$11.6 - $17.05
($13.85)
$ 7.09-49%New holding19,901
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SPPI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


SPPI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MAIDA ANTHONY E IIIDirector 2013-03-05Sell5,000$11.5-38.35view
MAIDA ANTHONY E IIIDirector 2013-02-05Sell5,000$12.25-42.12view
MAIDA ANTHONY E IIIDirector 2013-01-02Sell5,000$11.42-37.92view
SHROTRIYA RAJESH C MDChairman, CEO & President 2012-12-31Sell378,343$11.29-37.2view
MAIDA ANTHONY E IIIDirector 2012-12-04Sell5,000$11.65-39.14view
Keller Joseph KennethEVP & COO 2012-11-12Buy10,000$10.95-35.25view
MAIDA ANTHONY E IIIDirector 2012-11-01Sell5,000$11.09-36.07view
SHROTRIYA RAJESH C MDChairman, CEO & President 2012-10-09Sell11,350$12.5-43.28view
MAIDA ANTHONY E IIIDirector 2012-10-02Sell5,000$11.8-39.92view
Scott Brett LActing CFO 2012-10-01Sell6,000$12-40.92view

Quarterly/Annual Reports about SPPI:

News about SPPI:

Articles On GuruFocus.com
AT&T Will Benefit From DirecTV Acquistion Aug 14 2015 
Spectrum: Allos Acquisition Means Huge Upside Potential May 04 2012 
5 Stocks Exceeding Expectations In 2012 Mar 31 2012 
Was Gilead's Acquisition of Pharmasset a Dose of Bad Medicine? Mar 05 2012 
Spectrum Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 10 2011 
Weekly CFO Buys Highlight: CNYD, PRWT, ANCB, SPPI, SPAX Jan 30 2011 
Weekly CFO Buys Highlight: FUL, SPPI, GRF, BPAX Jan 24 2011 
Weekly Top Insider Buys: NPBC, FUL, GAM, SHLM, SPPI Jan 23 2011 
Spectrum Pharmaceuticals Inc. (SPPI) CFO Brett L Scott buys 4,000 Shares Jan 21 2011 
Spectrum Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 

More From Other Websites
Spectrum Pharmaceuticals Announces First Quarter 2016 Financial Results Teleconference and Webcast Apr 28 2016
Spectrum Pharmaceuticals Announces First Quarter 2016 Financial Results Teleconference and Webcast Apr 28 2016
This Biotech Is Up 300% In Two Months Apr 20 2016
Spectrum Pharma Jumps on FDA Orphan Designation Apr 20 2016
FDA Grants Orphan Drug Exclusivity to EVOMELA™ (melphalan) for Injection, Indicated for Multiple... Apr 20 2016
[$$] Companies Wind Up in the 'Penalty Box' on Executive Pay Apr 20 2016
[$$] Companies Wind Up in the ‘Penalty Box’ on Executive Pay Apr 20 2016
Four Biotech Stocks To Consider As The Sector Breaks Out Apr 07 2016
Existing Chemotherapy Drugs for Lymphoma Apr 07 2016
Six Technologies That Will Change Healthcare Apr 07 2016
ETF’s with exposure to Spectrum Pharmaceuticals, Inc. : March 28, 2016 Mar 28 2016
SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Mar 24 2016
SPECTRUM PHARMACEUTICALS INC Financials Mar 18 2016
FDA Grants Spectrum Pharmaceuticals Approval of EVOMELA™ (melphalan) for Injection Mar 15 2016
SPECTRUM PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Mar 14 2016
ETF’s with exposure to Spectrum Pharmaceuticals, Inc. : March 14, 2016 Mar 14 2016
XLV Rose Last Week, but Did It Reach Its 100-Day Moving Average? Mar 14 2016
Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 14 2016
SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events Mar 11 2016
Spectrum (SPPI) Incurs Narrower-than-Expected Loss in Q4 Mar 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)